Literature DB >> 30561633

Atrial fibrillation ablation in heart failure.

Sergio Richter1, Luigi Di Biase2, Gerhard Hindricks1.   

Abstract

This review summarizes the rationale and current scientific evidence for catheter ablation in patients with atrial fibrillation and concomitant heart failure, puts it in context with recent practice recommendations, and discusses emerging technologies and future directions. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation ; Catheter ablation ; Heart failure

Year:  2019        PMID： 30561633     DOI： 10.1093/eurheartj/ehy778

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  9 in total

1.  Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study.

Authors:  Langjing Huang; Zhihua Yu; Mei Liu; Xiaoke Shang
Journal:  Am J Cardiovasc Drugs       Date:  2022-06-18       Impact factor: 3.283

2.  Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure.

Authors:  Michelle Samuel; Michal Abrahamowicz; Jacqueline Joza; Marie-Eve Beauchamp; Vidal Essebag; Louise Pilote
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

3.  Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation.

Authors:  Micaela Ebert; Rebekka Karrengarn; Cosima Jahnke; Simon Kircher; Sabrina Oebel; Michael Döring; Gerhard Hindricks; Ingo Paetsch; Sergio Richter
Journal:  Int J Cardiol Heart Vasc       Date:  2021-12-29

4.  E/E' Is a New Independent Predictor of Recovered Ejection Fraction in Patients With Systolic Heart Failure Undergoing Ablation for Atrial Fibrillation.

Authors:  Minghui Yang; Rongfeng Zhang; Huamin Tang; Guocao Li; Xumin Guan; Yiheng Yang; Yuanjun Sun; Xianjie Xiao; Xiaohong Yu; Xiaomeng Yin; Yingxue Dong; Lianjun Gao; Yunlong Xia; Yanzong Yang
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 5.  Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation.

Authors:  Dan Li; Jiali Nie; Yu Han; Li Ni
Journal:  Front Cardiovasc Med       Date:  2022-01-21

Review 6.  Research progress of Nedd4L in cardiovascular diseases.

Authors:  Mohan Li; Guozhe Sun; Pengbo Wang; Wenbin Wang; Kexin Cao; Chunyu Song; Yingxian Sun; Ying Zhang; Naijin Zhang
Journal:  Cell Death Discov       Date:  2022-04-16

7.  Editorial: Epigenetic and transcriptional networks underlying ventricular and atrial arrhythmias.

Authors:  Yuanyuan Zhao; Dingsheng Jiang; Yong Xia
Journal:  Front Cardiovasc Med       Date:  2022-07-29

Review 8.  The management of atrial fibrillation in heart failure: an expert panel consensus.

Authors:  Dimitrios Farmakis; Christina Chrysohoou; Gregory Giamouzis; George Giannakoulas; Michalis Hamilos; Katerina Naka; Stylianos Tzeis; Sotirios Xydonas; Apostolos Karavidas; John Parissis
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

9.  Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure.

Authors:  Michelle Samuel; Michal Abrahamowicz; Jacqueline Joza; Vidal Essebag; Louise Pilote
Journal:  CJC Open       Date:  2020-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.